2022中国人体健康科技促进会皮肤病学术年会 暨免疫性皮肤病高峰论坛 征文通知

2022-09-13  中国人体健康科技促进会   网络

由中国人体健康科技促进会主办,中国人体健康科技促进会皮肤病专业委员会、北京长江药学发展基金会银屑病防治研究教育专项基金管理委员会和上海市中西医结合学会皮肤性病专业委员会联合承办的“2022

由中国人体健康科技促进会主办,中国人体健康科技促进会皮肤病专业委员会、北京长江药学发展基金会银屑病防治研究教育专项基金管理委员会和上海市中西医结合学会皮肤性病专业委员会联合承办的“2022中国人体健康科技促进会皮肤病学术年会暨免疫性皮肤病高峰论坛”定于2022年12月23日-12月25日在上海市召开。

此次会议将注重皮肤科相关领域的最新研究进展,尤其是免疫性皮肤病的规范诊疗及健康管理。会议将邀请知名专家做特邀演讲,并设有大会发言、分会发言、病例展示等交流方式,内容充实而形式多样。

欢迎踊跃投稿!

一、投稿要求

投稿内容:

中文全文和400字以内的中文摘要,皮肤科基础研究论文、皮肤科临床诊断和治疗等方面的论文、典型与疑难病例等;

投稿方式:

请通过电子邮件投稿,Email:pfkxh@126.com,并抄送至bg.ma@chstpa.com。来稿请注明“人体健康皮肤年会征文”,截稿日期:2022年11月20日;

会议交流形式:

特邀讲演、大会发言、分会发言、书面交流。

二、联系方式

《中国真菌学杂志》编辑部 施慧

电 话:021-8188 5497/13764560811

 箱:pfkxh@126.com

中国人体健康科技促进会 马保国

电 话:13911271690

邮 箱:bg.ma@chstpa.com

 中国人体健康科技促进会  

                                    2022年9月7日

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1748406, encodeId=e09c1e4840639, content=<a href='/topic/show?id=a1e44554368' target=_blank style='color:#2F92EE;'>#学术年会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45543, encryptionId=a1e44554368, topicName=学术年会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743c36117485, createdName=liuli5091, createdTime=Wed Nov 09 20:44:32 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662980, encodeId=e5b81662980f5, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Sat Oct 01 18:44:32 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826182, encodeId=46331826182cf, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Jan 11 13:44:32 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248752, encodeId=3f6a1248e524b, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Sep 13 22:30:33 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248793, encodeId=17961248e934d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Wed Sep 14 06:08:40 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1748406, encodeId=e09c1e4840639, content=<a href='/topic/show?id=a1e44554368' target=_blank style='color:#2F92EE;'>#学术年会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45543, encryptionId=a1e44554368, topicName=学术年会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743c36117485, createdName=liuli5091, createdTime=Wed Nov 09 20:44:32 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662980, encodeId=e5b81662980f5, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Sat Oct 01 18:44:32 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826182, encodeId=46331826182cf, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Jan 11 13:44:32 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248752, encodeId=3f6a1248e524b, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Sep 13 22:30:33 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248793, encodeId=17961248e934d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Wed Sep 14 06:08:40 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1748406, encodeId=e09c1e4840639, content=<a href='/topic/show?id=a1e44554368' target=_blank style='color:#2F92EE;'>#学术年会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45543, encryptionId=a1e44554368, topicName=学术年会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743c36117485, createdName=liuli5091, createdTime=Wed Nov 09 20:44:32 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662980, encodeId=e5b81662980f5, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Sat Oct 01 18:44:32 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826182, encodeId=46331826182cf, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Jan 11 13:44:32 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248752, encodeId=3f6a1248e524b, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Sep 13 22:30:33 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248793, encodeId=17961248e934d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Wed Sep 14 06:08:40 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1748406, encodeId=e09c1e4840639, content=<a href='/topic/show?id=a1e44554368' target=_blank style='color:#2F92EE;'>#学术年会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45543, encryptionId=a1e44554368, topicName=学术年会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743c36117485, createdName=liuli5091, createdTime=Wed Nov 09 20:44:32 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662980, encodeId=e5b81662980f5, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Sat Oct 01 18:44:32 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826182, encodeId=46331826182cf, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Jan 11 13:44:32 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248752, encodeId=3f6a1248e524b, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Sep 13 22:30:33 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248793, encodeId=17961248e934d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Wed Sep 14 06:08:40 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2022-09-13 ms5000000518166734

    学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1748406, encodeId=e09c1e4840639, content=<a href='/topic/show?id=a1e44554368' target=_blank style='color:#2F92EE;'>#学术年会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45543, encryptionId=a1e44554368, topicName=学术年会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=743c36117485, createdName=liuli5091, createdTime=Wed Nov 09 20:44:32 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662980, encodeId=e5b81662980f5, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Sat Oct 01 18:44:32 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826182, encodeId=46331826182cf, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Jan 11 13:44:32 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248752, encodeId=3f6a1248e524b, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Tue Sep 13 22:30:33 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248793, encodeId=17961248e934d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Wed Sep 14 06:08:40 CST 2022, time=2022-09-14, status=1, ipAttribution=)]
    2022-09-14 ms2000000057946177

    学习

    0

相关资讯

第二十六届长城会征文开始啦!

2015年10月29日-11月1日,承载老一辈心脏病学家厚爱、新一代心血管病学学者期望,沟通中外、传承未来的,第二十六届长城国际心脏病学会议、亚太心脏大会、国际心血管病预防与康复会议2015,将以全新的面貌在北京国家会议中心为您呈献!大会征文已经开始。 本届大会以“弥合裂痕,应对挑战”为主题,综合国内外知名学术组织和医疗机构,共同努力,弥合公共卫生、预防医学和临床医学的裂痕,应对NCD挑